BioBiz 2017, the biggest annual conference focusing on the biomedical and pharmaceutical sectors which is organised by NUS, was held on 1 April at Suntec City Convention Centre. The event seeks to inform and engage stakeholders in the biomedical ecosystem in Singapore. The conference was open to industry professionals, students from polytechnics and the Institute of Technical Education (ITE), and the institutes of higher learning, Singapore University of Technology and Design (SUTD) and Singapore Institute of Technology (SIT) and Nanyang Technological University (NTU).
In support of Singapore’s Skills Future mission, the event provided an avenue for students and professionals to realise their aspirations through a wide range of career opportunities, informative panel discussions and professional career workshops which provided educational and career guidance. The event also brought together employers and a pipeline of skilled and qualified employees.
BioBiz 2017 was graced by the Chief Executive of Workforce Singapore (WSG) Mr TAN Choon Shian. In his speech, Mr Tan said, “As a sign of Singapore’s commitment towards the biomedical sciences industry, the Government has invested up to $4 billion under the Research, Innovation and Enterprise (RIE) 2020 plan. The opportunities in the biomedical industry in Singapore are many, and increasing, as more companies establish their base here. This event is organised for students by students, and I am pleased to note that for the first time, we have the participation of industry, in addition to the local universities, the polytechnics and ITEs.”
Mr Rajesh Kumar SHARMA, Chairperson of BioBiz 2017, said, “For the last 12 years, BioBiz has served as a platform for key stakeholders in the biomedical sector - including students, professionals, companies and Government agencies - to meet, interact and network. BioBiz 2017 attracted a record attendance of 741 students and professionals from the biomedical industry. This was an exceptional turnout.”
Panellists and alumni from multinational corporations (MNCs), Government agencies, research institutes and small and medium enterprises (SMEs) engaged in insightful discussions on their work experiences and addressed participant queries. The panel discussion topics were wide-ranging, and included current trends and developments in the healthcare sector, skills required to succeed in the biotech industry and the challenges and rewards of working in a medical technology start-up company in a business environment with strong and established players.
Many of the attendees felt that the conference enhanced their understanding of the biomedical and pharmaceutical fields. It also provided them better understanding of the job opportunities available in these sectors through the host of panel discussions, networking sessions, company sharing sessions as well as booth presentations.
BioBiz 2017 was supported by e2i and sponsors including Illumina, Novartis, Alcon, Edwards Lifesciences, Amgen, Procter and Gamble, Abbvie, MDIS, Astra Zeneca, No Deviation, PSB Academy, GE Healthcare, LF Asia and Gamma2000; and partners Biotechin.Asia, Xfers, ISPE, Techuz Inforweb Pvt. Ltd. and Matthew James International.
Participants queued up at the registration booths of BioBiz 2017
Participants browsed through the BioBiz programme booklet before the start of a panel discussion at the main Summit Hall at Suntec City Convention Centre
The event chairperson Mr Rajesh Kumar Sharma delivered the opening speech
Guest-of-Honour, Mr Tan Choon Shian, delivered a speech about the Government’s initiatives to support and enhance the growth of the biomedical and pharmaceutical industries
The Chairperson presented a token of appreciation to the Guest-of-Honour
The panellists had lively discussions
Participants engaged in networking with the panellists, alumni and sponsor companies